|4Jan 14, 9:49 PM ET

Ashley Robert A. 4

4 · VITAL THERAPIES INC · Filed Jan 14, 2019

Insider Transaction Report

Form 4
Period: 2019-01-11
Ashley Robert A.
See Remarks
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-01-1123,3440 total
    Exercise: $0.43From: 2016-04-25Exp: 2022-04-24Common Stock (23,344 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-01-11241,6700 total
    Exercise: $8.00From: 2016-09-13Exp: 2022-09-25Common Stock (241,670 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-01-1175,0000 total
    Exercise: $3.20Exp: 2027-06-09Common Stock (75,000 underlying)
  • Award

    Restricted Stock Units

    2019-01-11+816,634816,634 total
    Common Stock (816,634 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-01-1175,0000 total
    Exercise: $8.28Exp: 2026-05-12Common Stock (75,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-01-1175,0000 total
    Exercise: $5.00Exp: 2028-06-08Common Stock (75,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-01-1193,3770 total
    Exercise: $0.43From: 2016-02-08Exp: 2022-03-31Common Stock (93,377 underlying)
Footnotes (6)
  • [F1]The option was cancelled by mutual agreement of the reporting person and Vital Therapies, Inc. The reporting person received a restricted stock unit award as reported in this Form 4 as consideration for this cancellation.
  • [F2]Subject to the reporting person continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan (the "Plan")), one forty-eighth (1/48th) of the shares subject to the option vested and became exercisable one month after the vesting commencement date of April 16, 2016, and an additional one forty-eighth (1/48th) of the shares vest and become exercisable at the end of each monthly period thereafter. One hundred percent (100%) of the unvested portion of the option, if any, shall vest in the event of a termination without cause following a Change in Control (as defined in the Plan).
  • [F3]Subject to the reporting person continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan (the "Plan")), one forty-eighth (1/48th) of the shares subject to the option vested and became exercisable one month after the vesting commencement date of June 10, 2017, and an additional one forty-eighth (1/48th) of the shares vest and become exercisable at the end of each monthly period thereafter. One hundred percent (100%) of the unvested portion of the option, if any, shall vest in the event of a termination without cause following a Change in Control (as defined in the Plan).
  • [F4]Subject to the reporting person continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan (the "Plan")), one forty-eighth (1/48th) of the shares subject to the option vested and became exercisable one month after the vesting commencement date of June 9, 2018, and an additional one forty-eighth (1/48th) of the shares vest and become exercisable at the end of each monthly period thereafter. One hundred percent (100%) of the unvested portion of the option, if any, shall vest in the event of a termination without cause following a Change in Control (as defined in the Plan).
  • [F5]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vital Therapies, Inc. Common Stock.
  • [F6]Subject to the reporting person continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), twenty five percent (25%) of the RSUs vest annually after the vesting commencement date of January 11, 2019. One hundred percent (100%) of the unvested portion of the RSUs, if any, shall vest in the event of a Termination without Cause or Resignation for Good Reason (each as defined in the reporting person's Change of Control and Severance Agreement).

Documents

1 file
  • 4
    wf-form4_154752054652794.xmlPrimary

    FORM 4